Matthew R. Allen
Department of Anatomy and Cell Biology
Indiana University School of Medicine
635 Barnhill Drive
MS-5035
USA
Name/email consistency: high
- Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone. Allen, M.R., Erickson, A.M., Wang, X., Burr, D.B., Martin, R.B., Hazelwood, S.J. Calcif. Tissue Int. (2010)
- Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs. Allen, M.R., Kubek, D.J., Burr, D.B. J. Bone Miner. Res. (2010)
- Higher bone matrix density exists in only a subset of patients with bisphosphonate-related osteonecrosis of the jaw. Allen, M.R., Ruggiero, S.L. J. Oral Maxillofac. Surg. (2009)
- Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench. Allen, M.R. Cells. Tissues. Organs. (Print) (2009)
- The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. Allen, M.R., Burr, D.B. J. Oral Maxillofac. Surg. (2009)
- Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Allen, M.R., Gineyts, E., Leeming, D.J., Burr, D.B., Delmas, P.D. Osteoporos. Int (2008)
- Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. Allen, M.R., Burr, D.B. J. Oral Maxillofac. Surg. (2008)
- Skeletal accumulation of bisphosphonates: implications for osteoporosis treatment. Allen, M.R. Expert. Opin. Drug. Metab. Toxicol (2008)
- Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs. Allen, M.R., Burr, D.B. Osteoporos. Int (2008)
- Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment. Allen, M.R., Reinwald, S., Burr, D.B. Calcif. Tissue Int. (2008)
- Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment. Allen, M.R., Burr, D.B. J. Bone Miner. Res. (2007)
- Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone. Allen, M.R., Hogan, H.A., Hobbs, W.A., Koivuniemi, A.S., Koivuniemi, M.C., Burr, D.B. Endocrinology (2007)
- Animal models of osteonecrosis of the jaw. Allen, M.R. J. Musculoskelet. Neuronal. Interact (2007)
- Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Allen, M.R., Iwata, K., Phipps, R., Burr, D.B. Bone (2006)
- Raloxifene enhances vertebral mechanical properties independent of bone density. Allen, M.R., Iwata, K., Sato, M., Burr, D.B. Bone (2006)
- Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib. Allen, M.R., Follet, H., Khurana, M., Sato, M., Burr, D.B. Calcif. Tissue Int. (2006)
- Differential bone and muscle recovery following hindlimb unloading in skeletally mature male rats. Allen, M.R., Hogan, H.A., Bloomfield, S.A. J. Musculoskelet. Neuronal. Interact (2006)
- Human femoral neck has less cellular periosteum, and more mineralized periosteum, than femoral diaphyseal bone. Allen, M.R., Burr, D.B. Bone (2005)
- Periosteum: biology, regulation, and response to osteoporosis therapies. Allen, M.R., Hock, J.M., Burr, D.B. Bone (2004)
